Angiotensin I converting enzyme inhibition and enzymatic resistance in vitro

International Dairy Journal

Volumn 24, Issue 1, 2012, Pages 27-32

  Sun, Hui ^a   Zhao, Xin Huai ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACE-INHIBITORY ACTIVITY; ALCALASE; ANGIOTENSIN I-CONVERTING ENZYME; CASEIN HYDROLYSATE; ENZYMATIC RESISTANCE; IN-VITRO; POTENTIAL IMPACTS; PRECIPITATE FRACTION; RESIDUAL ACTIVITY; SOLUBLE FRACTION; SOLVENT FRACTIONATION;

CASEIN; HYDROLYSIS; SOLVENTS;

ENZYME INHIBITION;

EID: 84862784553     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2011.11.012     Document Type: Article

References (42)

1. Adler-Nissen J. Determination of the degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. Journal of Agricultural and Food Chemistry 1979, 27:1256-1262.
2. Andrews A.T., Alichanidis E. The plastein reaction revisited: evidence for a purely aggregation reaction mechanism. Food Chemistry 1990, 35:243-261.
3. Belitz H.D., Gorsch W., Schieberle P. Food chemistry 2009, Springer-Verlag Berlin Heidelberg, Heidelberg, Germany, pp. 83-86. 4th ed.
4. Church F.C., Swaisgood H.E., Porter D.H., Catignani G.L. Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins. Journal of Dairy Science 1983, 66:1219-1227.
5. Clare D.A., Swaisgood H.E. Bioactive milk peptides: a prospectus. Journal of Dairy Science 2000, 83:1187-1195.
6. Combes D., Lozano P. α-Chymotrypsin in plastein synthesis. Influence of water activity. Annals of the New York Academy of Sciences 1993, 672:409-414.
7. Contreras M.M., Carrón R., Montero M.J., Ramos M., Recio I. Novel casein-derived peptides with antihypertensive activity. International Dairy Journal 2009, 19:566-573.
8. Contreras M.M., Sevilla A., Monroy-Ruiz J., Amigo L., Gómez-Sala B., Molina E., et al. Food-grade production of an antihypertensive casein hydrolysate and resistance of active peptides to drying and storage. International Dairy Journal 2011, 21:470-476.
9. Curis J.M., Dennis D., Waddell D.S., MacGillivray T., Ewart H.S. Determination of angiotensin-converting enzyme inhibitory peptide Leu-Lys-Pro-Asn-Met (LKPNM) in bonito muscle hydrolysates by LC-MS/MS. Journal of Agricultural and Food Chemistry 2002, 50:3919-3925.
10. Gómez-Ruiz J.A., Ramos M., Recio I. Angiotensin-converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion. International Dairy Journal 2004, 14:1075-1080.
11. Hang M., Zhao X.H. Fermentation time and extraction solvents influenced in vitro antioxidant property of soluble extracts of mao-tofu fermented with Mucor spp. Biotechnology 2011, 10:60-69.
12. Haque E., Chand R. Antihypertensive and antimicrobial bioactive peptides from milk proteins. European Food Research and Technology 2008, 227:7-15.
13. Hernández-Ledesma B., Amigo L., Ramos M., Recio I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. Journal of Agricultural and Food Chemistry 2004, 52:1504-1510.
14. IDF Determination of the nitrogen (Kjeldahl method) and calculation of the crude protein content. IDF Standard 20B 1993, International Dairy Federation, Brussels, Belgium.
15. Jauhiainen T., Wuolle K., Vapaatalo H., Kerojoki O., Nurmela K., Lowrie C., et al. Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats. International Dairy Journal 2007, 17:1216-1223.
16. Kunst T. Protein modification to optimize functionality: protein hydrolysates. Handbook of food enzymology 2003, 221-236. Marcel Dekker, New York, NY, USA. J.R. Whitaker, A.F.J. Voragen, D.W.S. Wong (Eds.).
17. Kwan L., Chan L.E., Helbig N., Nakai S. Fractionation of water-soluble and insoluble components from egg yolk with minimum use of organic solvents. Journal of Food Science 1991, 56:1537-1541.
18. López-Fandiño R., Otte J., van Camp J. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. International Dairy Journal 2006, 16:1277-1293.
19. Mao X.Y., Ni J.R., Sun W.L., Hao P.P., Fan L. Value-added utilization of yak milk casein for the production of angiotensin-I-converting enzyme inhibitory peptides. Food Chemistry 2007, 103:1282-1287.
20. Miguel M., Aleixandre M.A., Ramos I., López-Fandiño R. Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin. Journal of Agricultural and Food Chemistry 2006, 54:726-731.
21. Miguel M., Contreras M.M., Recio I., Aleixandre A. ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate. Food Chemistry 2009, 112:211-214.
22. Mullally M.M., Meisel H., FitzGerald R.J. Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins. International Dairy Journal 1997, 7:299-303.
23. Murray B.A., Walsh D.J., FitzGerald R.J. Modification of the furanacryloyl-L-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity. Journal of Biochemical and Biophysical Methods 2004, 59:127-137.
24. Ono S., Kasai D., Sugano T., Ohba K., Takahashi K. Production of water soluble antioxidantive plastein from squid hepatopancreas. Journal of Oleo Science 2004, 53:267-273.
25. Oshima G., Shimabukuro H., Nagasawa K. Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase. Biochimica et Biophysica Acta 1979, 566:128-137.
26. Otte J., Shalaby S.M., Zakora M., Pripp A.H., El-Shabrawy S.A. Angiotensin- converting enzyme inhibitory activity of milk protein hydrolysates: effect of substrate, enzyme and time of hydrolysis. International Dairy Journal 2007, 17:488-503.
27. Pan D., Luo Y., Tanokura M. Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004. Food Chemistry 2005, 91:123-129.
28. Phelan M., Aherne A., FitzGerald R.J., O'Brien N.M. Casein-derived bioactive peptides: biological effects, industrial uses, safety aspects and regulatory status. International Dairy Journal 2009, 19:643-654.
29. Pihlanto-Leppälä A. Bioactive peptides derived from bovine proteins: opioid and ACE-inhibitory peptides. Trends in Food Science and Technology 2000, 11:347-356.
30. Quirós A., Contreras M.D.M., Ramos M., Amigo L., Recio I. Stability to gastrointestinal enzymes and structure-activity relationship of β-casein-peptides with antihypertensive properties. Peptides 2009, 30:1848-1853.
31. Sarath G., De La Motte R.S., Wagner F.W. Protease assay methods. Proteolytic enzymes: A practical approach 1989, 25-55. IRL Press, Oxford, UK. R.J. Beynon, J.S. Bond (Eds.).
32. Shalaby S.M., Zakora M., Otte J. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. Journal of Dairy Research 2006, 73:178-186.
33. Silva S.V., Malcata F.X. Caseins as source of bioactive peptides. International Dairy Journal 2005, 15:1-15.
34. Stevenson D.E., Morgan K.R., Fenton G.A., Moraes G. Use of NMR and mass spectrometry to detect and quantify protease-catalyzed peptide bond formation in complex mixtures. Enzyme and Microbial Technology 1999, 25:357-363.
35. Stevenson D.E., Ofman D.J., Morgan K.R., Stanley R.A. Protease-catalyzed condensation of peptides as a potential means to reduce the bitter taste of hydrophobic peptides found in protein hydrolysates. Enzyme and Microbial Technology 1998, 22:100-110.
36. Wu J., Ding X. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry 2001, 49:501-506.
37. Yamashita M., Arai S., Fujimaki M. Plastein reaction for food protein improvement. Journal of Agricultural and Food Chemistry 1976, 24:1100-1104.
38. Yamashita M., Arai S., Fujimaki M. A low-phenylalenine, high-tyrosine plastein as an acceptable dietetic food. Journal of Food Science 1976, 41:1029-1032.
39. Yoshii H., Tachi N., Ohba R., Sakamura O., Takeyama H., Itani T. Antihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks. Comparative Biochemistry Physiology C: Pharmacology Toxicology and Endocrinology 2001, 128:27-33.
40. Zhang F., Wang Z., Xu S. Macroporous resin purification of grass carp fish (Ctenopharyngodon idella) scale peptides with in vitro angiotensin-I converting enzyme (ACE) inhibitory ability. Food Chemistry 2009, 117:387-392.
41. Zhao X.H., Li Y.Y. An approach to improve ACE inhibitory activity of casein hydrolysates with plastein reaction catalyzed by Alcalase. European Food Research and Technology 2009, 229:795-805.
42. Zhao X.H., Wu D., Li T.J. Preparation and the radical scavenging activity of papain catalyzed casein plasteins. Dairy Science and Technology 2010, 90:521-535.